Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
Rosacea is a chronic condition characterized by facial erythema (redness) and sometimes pimples. Rosacea affects all ages and has four subtypes, three affecting the skin and the fourth affecting the eyes (ocular type). Left untreated it worsens over time. Treatment in the form of topical steroids can aggravate the condition. Rosacea Medicine Conference provides wide range knowledge of the latest on the diagnosis, prevention, and treatment of dermatologic disease from the foremost experts in the field. Treatment through behavior, medication and laser is prescribed. One of the many conditions discussed during the conference was rosacea, which causes erythema, pimples, pustules and a flushing and blushing phenomenon.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Rosacea was considered as a rare disease. It soon became evident; however, that rosacea affected the lives of untold millions, who had previously failed to realize they had a medical condition that could be treated. We wish to spread awareness among individuals by bringing forward a lot of researchers on a common ground and to be a part of International Conferences, Workshops, Symposium and events provides more scope to learn by international scientists and academicians. A conference will offer excessive quality content to suit the diverse professional development of these procedures to treat people all over the globe. It is a perfect platform to discuss the current discoveries and developments in the field.
It primarily affects people of northwestern European descent and has been nicknamed the 'curse of the Celts' by some in Britain and Ireland, although recently this has been questioned. Rosacea affects both sexes, but is almost three times more common in women. It has a peak age of onset between 30 and 60. Rosacea typically begins as redness on the central face across the cheeks, nose, or forehead, but can also less commonly affect the neck, chest, ears, and scalp. In some cases, additional symptoms, such as semi-permanent redness, telangiectasia (dilation of superficial blood vessels on the face), red domed papules (small bumps) and pustules, red gritty eyes, burning and stinging sensations, and in some advanced cases, a red lobulated nose may develop. Rosacea is a skin disease typically appearing in people during their 30s and 40s. It is marked by redness (erythema) of the face, flushing of the skin, and the presence of hard pimples (papules) or pus-filled pimples (pustules), and small visible spider-like veins called telangiectasias. In later stages of the disease, the face may swell and the nose may take on a bulb-like appearance called rhinophyma. Mild cases are often not treated at all, or are simply covered up with normal cosmetics. Therapy for the treatment of rosacea is not curative, and is best measured in terms of reduction in the amount of erythema and inflammatory lesions, decrease in the number, duration, and intensity of flares, and concomitant symptoms of itching, burning, and tenderness. The two primary modalities of rosacea treatment are topical and oral antibiotic agents. Laser therapy has also been classified as a form of treatment. While medications often produce a temporary remission of redness within a few weeks, the redness typically returns shortly after treatment is suspended. Long-term treatment, usually one to two years, may result in permanent control of the condition for some patients.
The global market for bariatric surgery devices was worth nearly $1.1 billion in 2012. The market is expected to reach nearly $1.2 billion in 2013 and almost $1.9 billion by 2018, with a compound annual growth rate (CAGR) of 9.6% between 2013 and 2018. North America dominates the overall bariatric surgery devices market owing to the presence of a large number of obese population with unmet medical needs coupled with the presence of high patient awareness levels. According to the U.S. CDC, an estimated 200 million adults or 68% of the total adult population in the U.S. are obese. In addition, high prevalence of type-2 diabetes as a result of the large number of population suffering from obesity will serve the North America bariatric surgery devices market. The Asia-Pacific region however, will grow at the fastest rate from 2013 to 2020. High prevalence of diabetes coupled with rapidly improving healthcare infrastructure in emerging countries such as India and China accounts for the aforementioned fact.
List of Best International Conferences:
Relevant Society and Associations
This page will be updated regularly.
This page was last updated on July 27, 2021